CQDM, Diazon and the Oncopole in collaboration with Mitacs announce the two laureates of the 2019 Gordon Shore Prize

News & Events

CQDM, Diazon and the Oncopole in collaboration with Mitacs announce the two laureates of the 2019 Gordon Shore Prize, a mark of excellence for new graduates in life sciences Montreal, May 22, 2019 – CQDM, Diazon Pharmaceuticals, the Oncopole, and Mitacs, are delighted to announce the two laureates of the 2019 Gordon Shore Prize: Rachel Jodoin and Shilpa Chennakrishnaiah. Created … Read More

Hope on the horizon for hard-to-treat breast cancers

News & Events

Unique multi-party collaboration forged to develop new anti-cancer therapies targeting DNA repair regulators Montreal, Canada, May 14, 2019 – The NEOMED Institute (NEOMED), CQDM, the Canadian Cancer Society (CCS), the Goodman Cancer Research Centre (GCRC) and the Lady Davis Institute (LDI) announced today a unique multi-party collaboration to develop new anti-cancer therapies. This collaboration is intended to more rapidly advance two … Read More

CQDM, HBHL, Corbin Therapeutics and Brain Canada award $1.5 M to McGill Prof. Philippe Gros

News & Events

Montreal, May 2nd, 2019 – CQDM is pleased to announce that Professor Philippe Gros from McGill University has been awarded $1.5 million as part of the SynergiQC program to pursue the development and validation of new inhibitors of ubiquitin-specific protein protease (USP-15) and its partner TRIM25, that plays a key role in neuroinflammation-based disorders. From this development, Dr. Gros aims to … Read More

We are RECRUITING! Interested in a Project Coordinator position? Apply now!

News & Events

À PROPOS DU CQDM Le CQDM est un consortium de recherche biopharmaceutique fondé en 2008 qui a pour mission de financer le développement de technologies novatrices destinées à accélérer la découverte et la mise au point de médicaments. Notre modèle d’affaires privilégie une approche collaborative où les grandes entreprises pharmaceutiques mondiales, les sociétés de biotechnologie canadiennes, ainsi que les gouvernements … Read More

We are RECRUITING! Interested in a Artificial Intelligence Project Manager position? Apply now!

News & Events

About CQDM CQDM is a biopharma-based research consortium created in 2008 with the mission to fund the development of innovative technologies to accelerate the drug discovery and development. Its business model is based on a collaborative approach bringing together world-leading pharmaceutical organizations, Canadian biotech companies as well as the Canadian and Quebec governments who share the costs of the research. … Read More

IMV and CRCHU de Québec-U Laval Collaboration Awarded a CQDM Grant to Develop First-in-class Dual Target T cell Therapy in Bladder Cancer Based on IMV’s DPX Technology

News & Events

Two antigens are targeted in combination with the DPX technology developed by IMV Quebec City, Quebec, March 18, 2019 – IMV Inc. (IMV) (Nasdaq: IMV; TSX: IMV), a clinical stage immuno-oncology corporation, today announced that Canadian bioresearch consortium CQDM has awarded a grant to a collaboration among IMV, Centre de recherche du CHU de Québec-Université Laval, and La Fondation du … Read More

Call for Applications for the Gordon Shore Prize – Internships for new graduates

News & Events

Created by CQDM, Diazon Pharmaceuticals, the Oncopole, and Mitacs, the Gordon Shore Prize is awarded to new graduates whose masters or doctoral thesis demonstrated their research excellence in the life science field. A 6-month post-diploma internship of $24,000 will be offered to each of the awardees by the participating Quebec-based companies: SpecificiT Pharma Inc., Immune Biosolutions Inc. et IMV Inc. To … Read More

Philippe Walker appointed Member of the Scientific Advisory Board of CQDM

News & Events

Montreal, January 29th, 2019. – CQDM is pleased to announce the appointment of Philippe Walker as a member of CQDM’s Scientific Advisory Board. Philippe already knows CQDM very well since he has contributed very closely to its creation and success. Philippe has over 30 years of experience in pharmaceutical research and development in several therapeutic areas. He moved to Montreal … Read More

Call for Proposal to Private Companies – Post-Diploma Internships Co-Funded through the Gordon Shore Prize

News & Events

Private companies based in Quebec with life sciences-related activities are invited to offer two 6-month post-diploma internship positions for new graduates (Masters and PhD), future awardees of the Gordon Shore Prize. The Funders of this award, CQDM, Diazon, the Oncopole and Mitacs will finance 50 % of these post-diploma internships. The company must agree to pay the other half of … Read More

Merck Canada reaffirms its commitment to CQDM with a $3.5M contribution to sustain innovation in Life Sciences

News & Events

Montreal, Quebec – November 19, 2018 – CQDM is delighted to announce that Merck Canada, a founding member of the consortium, is renewing its commitment with a $3.5M contribution to support the development of disruptive technologies in biopharmaceutical research in Quebec and Canada. The research and development projects funded as part of this initiative will be selected through the CQDM … Read More